Upload
lamont
View
13
Download
0
Embed Size (px)
DESCRIPTION
Likely diagnosis of gout (exclude septic arthritis). Acute Treatment Treat pain and inflammation as soon as possible, continuing until acute flare has settled Full dose NSAID (eg naproxen 500mg bd or diclofenac 50mg tid +/- PPI) or Full dose oral Colchicine (500mcg 2-4 times daily) or - PowerPoint PPT Presentation
Citation preview
sUA <0.36mmol/l
Acute Treatment
Treat pain and inflammation as soon as possible, continuing until acute flare has settled
• Full dose NSAID (eg naproxen 500mg bd or diclofenac 50mg tid +/- PPI) or
• Full dose oral Colchicine (500mcg 2-4 times daily) or
• Cortico-steroid (oral prednisolone 30mg od for 5 days or IM methyl prednisolone 80-120mg. Where expertise is available consider IA methylprednisolone 40-80mg or triamcinolone 20-40mg)
Advise patient to apply an ice pack periodically to affected joint (wrap in a towel to avoid ice burn)
Review appointment (4-6 weeks)
• Assess lifestyle factors, blood pressure, lipid profile and perform serum urate, kidney and liver function & glucose
• Optimise weight, increase exercise, modify diet, reduce alcohol, treat underlying cardiovascular risk factors
Long term treatment
• Initiate urate lowering therapy if patient has had ≥2 flares per year based on patient preference and clinical judgement
• First line treatment Allopurinol, Second line Febuxostat, Third line Sulphinpyrazone
• Co-prescribe low dose NSAID(eg naproxen 250mg bd or diclofenac 25mg TID) +/- PPI or low dose colchicine (500mcg 2 times daily) for at least 6 weeks
Reconsider diagnosis
• Persistent symptoms without diagnosis should be referred to secondary care. Note that serum urate frequently falls
during gout attacks, so it is important that serum urate is measured after resolution
of the flare.
sUA ≥ 0.36mmol/l
Repeat sUA (2-4 weeks)
sUA ≥ 0.36mmol/lsUA <0.36mmol/l
•Titrate up urate lowering therapy (please see separate flow chart for prescribing in renal impairment and details of drug dosage)
• Maintain prophylactic colchicine for up to 6 months during dose titration
Continue urate lowering therapy unless causing side effects
Repeat convalescent serum urate in patients suffering recurrent attacks
Likely diagnosis of gout (exclude septic arthritis)
Start 100mg allopurinol od
Maximum 900mg od
eGFR <10
Commence 80mg febuxostat od with 6 months colchicine 500mcg 1-2 tab daily if tolerated
Escalate to 120mg febuxostat od after 2-4 weeks if target urate not achieved
Start sulfinpyrazone 200mg od and titrate to maximum 800mg od
Consider adding allopurinol if no contra-indication
Refer to secondary care for consideration of benzbromarone +/- further allopurinol titration
Intolerance or inefficacy of febuxostat
Continue urate lowering therapy through any subsequent attacks
Check convalescent serum urate in patients suffering recurrent attacks and escalate treatment if no longer at target
Sulfinpyrazone dose may be reduced for maintenance
Intolerance/inefficacy of sulfinpyrazone
+/- allopurinol
Intolerance or inefficacy of allopurinol
Urate Lowering Therapy prescribing based on renal function
Offer flare prophylaxis for at least 6 weeks with 500mcg colchicine od or bd if tolerated. Measure serum urate every 2-4 weeks and titrate therapy until target of serum urate <0.36mmol/l. Check compliance before assuming inefficacy.
Target urate achieved
Start 50mg allopurinol od
Maximum 100mg od
eGFR 20-50eGFR 10-20 eGFR >50
Start 100mg allopurinol od
Maximum 200mg od
Start 100mg allopurinol od
Maximum 300mg od
eGFR >= 30
eGFR >=90
eGFR <30
eGFR <90
or
or
or
Target urate achieved
Target urate achieved